In the last trading session, 0.21 million shares of the Fulgent Genetics Inc (NASDAQ:FLGT) were traded, and its beta was 1.05. Most recently the company’s share price was $20.31, and it changed around -$0.21 or -1.02% from the last close, which brings the market valuation of the company to $618.31M. FLGT currently trades at a discount to its 52-week high of $25.11, offering almost -23.63% off that amount. The share price’s 52-week low was $14.57, which indicates that the current value has risen by an impressive 28.26% since then.
Fulgent Genetics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.67. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 2 recommended FLGT as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Fulgent Genetics Inc is expected to report earnings per share of -0.18 for the current quarter.
Fulgent Genetics Inc (NASDAQ:FLGT) trade information
Instantly FLGT has showed a red trend with a performance of -1.02% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 21.42 on recent trading dayincreased the stock’s daily price by 5.18%. The company’s shares are currently up 9.96% year-to-date, but still down -0.20% over the last five days. On the other hand, Fulgent Genetics Inc (NASDAQ:FLGT) is 6.67% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $25, which translates to bulls needing to increase their stock price by 18.76% from its current value. Analyst projections state that FLGT is forecast to be at a low of $25 and a high of $25.
Fulgent Genetics Inc (FLGT) estimates and forecasts
The year-over-year growth rate is expected to be 9.60%, up from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of 76.21M in revenue for the current quarter. 3 analysts expect Fulgent Genetics Inc to make 78.47M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 71.03M and 71.74M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 7.29%. Forecasts for the next quarter put sales growth at 9.38%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -129.89%.
FLGT Dividends
Fulgent Genetics Inc’s next quarterly earnings report is expected to be released in June.
VANGUARD GROUP INC, with 4.7692% or 1.44 million shares worth $28.16 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF were the top two Mutual Funds as of Dec 31, 2024 . The former held 604.63 shares worth $12.28 million, making up 1.99% of all outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held roughly 535.78 shares worth around $10.88 million, which represents about 1.76% of the total shares outstanding.
